2024-11-11T10:13:55-06:00 2023-12-31 521711839 COUNCILOR BUCHANAN & MITCHELL PC 7910 WOODMONT AVE STE 500 BETHESDA MD 20814 990 2023-01-01 522252820 ASSOCIATION FOR ACCESSIBLE MEDICINES ASSO 2022497100 601 NEW JERSEY AVENUE NW 850 WASHINGTON DC 20001 DAVID GAUGH INTERIM PRESIDENT & CEO 2022497100 2024-11-08 1 0 MARK C THOMAS P00362982 3019860600 2024-11-08 2023 2024-10-15 13:58:12Z JOHN A MURPHY III 601 NEW JERSEY AVENUE NW 850 WASHINGTON DC 20001 22235390 0 X WWW.ACCESSIBLEMEDS.ORG X 2000 DC PROMOTE THE INTEREST OF THE GENERIC PHARMACEUTICAL AND BIOSIMILAR INDUSTRY. 21 21 32 330 0 0 0 0 22237409 21263207 18658 578548 405939 393635 22662006 22235390 275700 319150 0 0 10900171 6900923 0 0 0 13675570 10728780 24851441 17948853 -2189435 4286537 27489220 23610075 20279874 12114192 7209346 11495883 THE ORGANIZATION FOSTERS AND PROMOTES THE INTERESTS OF THE GENERIC PHARMACEUTICAL AND BIOSIMILARS INDUSTRY. 0 0 GOVERNMENT AFFAIRS - ADVOCATE ON BEHALF OF THE GENERIC PHARMACEUTICAL AND BIOSIMILARS INDUSTRY WITH RESPECT TO FEDERAL, STATE, AND MUNICIPAL RULES, LAWS, AND ORDERS AFFECTING THE INDUSTRY. POLICY & STRATEGIC ALLIANCES - IDENTIFY POLICY ISSUES AFFECTING THE GENERIC PHARMACEUTICAL AND BIOSIMILARS INDUSTRIES AND FACILITATE DEVELOPMENT OF POLICY POSITIONS AMONG OUR MEMBER COMPANIES; WORK WITH THE AGENCIES OF THE U.S. GOVERNMENT, AND STATE AND INTERNATIONAL BODIES TO EDUCATE AND COMMUNICATE POLICY POSITIONS ON STRATEGIC PRIORITIES; DEVELOP DATA TO SUPPORT ADVOCACY INITIATIVES AND PUBLISH WHITE PAPERS, REPORTS AND OTHER POLICY RESOURCES; BUILD RELATIONSHIPS WITH THIRD-PARTY STAKEHOLDERS ACROSS SUPPLY CHAIN, PATIENT, PROVIDER, CONSUMER, AND OTHER SECTORS TO SUPPORT ADVOCACY INITIATIVES. COMMUNICATIONS & MARKETING - EDUCATING POLICYMAKERS, MEDIA, PATIENTS AND OTHER STAKEHOLDERS ABOUT THE ECONOMIC AND THERAPEUTIC CONTRIBUTIONS OF GENERIC AND BIOSIMILARS MEDICINES AS WELL AS THEIR SAFETY AND EFFICACY; PRODUCING AND SHARING PATIENT AND TAXPAYER SAVINGS DATA AND STORIES OF PATIENTS WHOSE HEALTH IS SAVED, IMPROVED AND MAINTAINED BY GENERIC AND BIOSIMILARS MEDICINES; DISSEMINATING INSTRUCTIONAL MATERIALS AND CURRICULUM TO PROMOTE THE SAFE USE, STORAGE AND DISPOSAL OF PRESCRIPTION MEDICINES. 0 0 0 1 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 59 0 1 32 1 0 0 0 0 0 0 0 0 0 0 X 21 21 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 X THE ASSOCIATION 2022497100 601 NEW JERSEY AVE NW SUITE 850 WASHINGTON DC 20001 CHRYS KOKINO BOARD MEMBER 2.00 X 0 0 0 JEFF BURD TREASURER 2.00 X X 0 0 0 GRETCHEN FRITZ BOARD MEMBER 2.00 X 0 0 0 MARYLL TOUFANIAN BOARD MEMBER 2.00 X 0 0 0 DAN DISHNER BOARD MEMBER 2.00 X 0 0 0 CHRISTINE BAEDER CHAIR 2/2023-12/2023 2.00 X X 0 0 0 PAUL MCMAHON BOARD MEMBER 2.00 X 0 0 0 ROB ALBERT BOARD MEMBER 2.00 X 0 0 0 ARUNESH VERMA BOARD MEMBER 2.00 X 0 0 0 JOHN DUCKER BOARD MEMBER 2.00 X 0 0 0 SANJEEV KRISHAN BOARD MEMBER 2.00 X 0 0 0 BRIAN HOFFMAN BOARD MEMBER 2.00 X 0 0 0 TOM SHEA BOARD MEMBER 2.00 X 0 0 0 BRANDON ROCKWELL BOARD MEMBER 2.00 X 0 0 0 KEREN HARUVI CHAIR BEGINNING 12/2023 2.00 X X 0 0 0 ABHAY GANDHI BOARD MEMBER 2.00 X 0 0 0 PATRICK MCINTOSH BOARD MEMBER 2.00 X 0 0 0 SANJAY GUPTA BOARD MEMBER 2.00 X 0 0 0 CRYSTAL FISHER BOARD MEMBER 2.00 X 0 0 0 KEVIN FORTIER BOARD MEMBER 2.00 X 0 0 0 BOB HOFFMAN BOARD MEMBER 2.00 X 0 0 0 JEFF HAMPTON BOARD MEMBER 2.00 X 0 0 0 PAUL DIOLOSA BOARD MEMBER 2.00 X 0 0 0 PETER HARDWICK BOARD MEMBER 2.00 X 0 0 0 VANESSA BRILL BOARD MEMBER 2.00 X 0 0 0 PETER KAEMMERER BOARD MEMBER 2.00 X 0 0 0 CHIRAG PATEL BOARD MEMBER 2.00 X 0 0 0 DAVID GAUGH INTERIM PRESIDENT & CEO 40.00 X 750530 0 49546 KARIN HESSLER GENERAL COUNSEL AND SECRETARY 40.00 X 442521 0 36514 CRAIG BURTON SVP POLICY & STRATEGIC ALL 40.00 X 441340 0 52881 GIUSEPPE RANDAZZO SVP, SCIENCE AND REGULATORY AFFAIRS 40.00 X 420617 0 16012 KATHERINE RAAB VP FEDERAL GOVERNMENT AFFAIRS 40.00 X 342323 0 41846 JOANNE DUNCAN FORMER COO 0.00 X 114750 0 0 DAN LEONARD FORMER PRESIDENT & CEO 0.00 X 413527 0 0 ALLEN GOLDBERG SVP, COMMUNICATIONS 40.00 X 301083 0 15028 ERIK KOMENDANT SVP GOVERNMENT AFFAIRS 40.00 X 260869 0 11724 3487560 0 223551 20 1 1 0 GOODWIN PROCTER 100 NORTHERN AVE BOSTON MA 02210 LEGAL 838385 IQVIA INC 100 IMS DR PARSIPPANY NJ 07054 RESEARCH STUDIES 696539 CORE STAGING INC 1137 E MARION ST STE 228 SHELBY NC 28150 MEETING A/V, STAGING & PRODUCTION 543091 KIRKLAND & ELLIS 601 LEXINGTON AVE NEW YORK NY 10022 LEGAL 379201 AVALERE HEALTH 1201 NEW YORK AVE NW STE 1000 WASHINGTON DC 20005 CONSULTING & DATA ANALYTICS 277000 23 MEMBERSHIP DUES 900099 19164854 19164854 MEETING REVENUE 900099 1588353 1588353 BIOSIMILAR COUNCIL DUES 900099 510000 510000 21263207 578548 578548 390635 0 390635 390635 390635 MISCELLANEOUS 900099 3000 3000 3000 22235390 21266207 0 969183 X 319150 1279111 4691380 224350 372335 333747 1013006 150316 1961379 2894738 168631 189101 258701 1266233 150580 1136050 279061 70966 RESEARCH PROJECT 590506 DUES & SUBSCRIPTIONS 512399 MAINTENANCE & TAXES 87113 17948853 9388789 0 6890189 17046731 119978 478899 462864 2731874 1890063 1122516 841811 413257 3247147 579013 5828445 4679656 27489220 23610075 1121082 754378 10696433 4830945 8462359 6528869 20279874 12114192 X 7209346 11495883 7209346 11495883 27489220 23610075 4286537 0 X X 0 1 X 1 0 0 0 0 19674854 4310341 -14075590 -9765249 6886199 -16651448 1752500 1003783 748717 866098 773004 93094 113276 113276 0 841811 DEPOSITS 34274 OPERATING RIGHT-OF-USE ASSETS 4645382 4679656 OPERATING LEASE LIABILITIES 6528869 6528869 X 22235390 0 22235390 0 22235390 17948853 0 17948853 0 17948853 PART X, LINE 2: THE ASSOCIATION REQUIRES THAT A TAX POSITION BE RECOGNIZED OR DERECOGNIZED BASED ON A "MORE-LIKELY-THAN-NOT" THRESHOLD. THIS APPLIES TO POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THE ASSOCIATION DOES NOT BELIEVE ITS FINANCIAL STATEMENTS INCLUDE, OR REFLECT, ANY UNCERTAIN TAX POSITIONS. THE ASSOCIATION'S TAX RETURNS ARE SUBJECT TO EXAMINATION BY THE TAXING AUTHORITIES GENERALLY FOR THREE YEARS AFTER FILING. 0 AMERICAN PHARMACISTS ASSOCIATION 2215 CONSTITUTION AVE NW WASHINGTON DC 20037 530026265 501(C)(6) 121650 0 GENERAL CONTRIBUTION INFORMATION TECHNOLOGY AND INNOVATION FOUNDATION 700 K ST NW STE 600 WASHINGTON DC 20001 204403497 501(C)(3) 10500 0 GENERAL CONTRIBUTION CENTER OF THE AMERICAN EXPERIMENT 8421 WAYZATA BLVD STE 110 GOLDEN VALLEY MN 55426 363611426 501(C)(3) 10000 0 GENERAL CONTRIBUTION NATIONAL MULTIPLE SCLEROSIS SOCIETY 900 SOUTH BROADWAY 2ND FL DENVER CO 80209 135661935 501(C)(3) 10000 0 GENERAL CONTRIBUTION R STREET INSTITUTE 1212 NEW YORK AVE NW STE 900 WASHINGTON DC 20005 263477125 501(C)(3) 10000 0 GENERAL CONTRIBUTION ALLIANCE FOR RETIRED AMERICANS 815 16TH ST NW 4TH FLOOR N WASHINGTON DC 20006 522277805 501(C)(3) 8000 0 GENERAL CONTRIBUTION NATIONAL CONSUMERS LEAGUE 1701 K ST NW STE 1200 WASHINGTON DC 20006 530242038 501(C)(3) 7500 0 GENERAL CONTRIBUTION THE HEARTLAND INSTITUTE 3939 N WILKE RD ARLINGTON HEIGHTS IL 60004 363309812 501(C)(3) 6000 0 GENERAL CONTRIBUTION 7 1 X X X 1 1 X X X X X X 1 0 0 DAVID GAUGH INTERIM PRESIDENT & CEO 468637 0 281893 0 0 0 26400 0 23146 0 800076 0 0 0 CRAIG BURTON SVP POLICY & STRATEGIC ALL 318383 0 122957 0 0 0 22500 0 30381 0 494221 0 0 0 KARIN HESSLER GENERAL COUNSEL AND SECRETARY 320174 0 122347 0 0 0 22500 0 14014 0 479035 0 0 0 GIUSEPPE RANDAZZO SVP, SCIENCE AND REGULATORY AFFAIRS 297027 0 123590 0 0 0 12348 0 3664 0 436629 0 0 0 DAN LEONARD FORMER PRESIDENT & CEO 0 0 0 0 413527 0 0 0 0 0 413527 0 413527 0 KATHERINE RAAB VP FEDERAL GOVERNMENT AFFAIRS 262397 0 79926 0 0 0 21314 0 20532 0 384169 0 0 0 ALLEN GOLDBERG SVP, COMMUNICATIONS 87950 0 0 0 213133 0 7111 0 7917 0 316111 0 0 0 ERIK KOMENDANT SVP GOVERNMENT AFFAIRS 87520 0 0 0 173349 0 7041 0 4683 0 272593 0 0 0 JOANNE DUNCAN FORMER COO 0 0 0 0 114750 0 0 0 0 0 114750 0 0 0 PART I, LINE 4A DURING THE YEAR ENDED DECEMBER 31, 2023, DAN LEONARD RECEIVED A 457(F) SUPPLEMENTAL NON-QUALIFIED RETIREMENT PLAN DISTRIBUTION OF $413,527 THAT WAS INCLUDED IN REPORTABLE WAGES. DURING THE YEAR ENDED DECEMBER 31, 2023, ALLEN GOLDBERG RECEIVED SEVERANCE PAYMENTS OF $213,133. DURING THE YEAR ENDED DECEMBER 31, 2023, ERIK KOMENDANT RECEIVED SEVERANCE PAYMENTS OF $173,349. DURING THE YEAR ENDED DECEMBER 31, 2023, JOANNE DUNCAN RECEIVED SEVERANCE PAYMENTS OF $114,750. FORM 990, PART VI, SECTION A, LINE 6 AAM HAS ONE CLASS OF REGULAR VOTING MEMBERS THAT MUST MEET THE FOLLOWING CRITERIA. A REGULAR MEMBER SHALL BE A CORPORATION, PARTNERSHIP OR OTHER LEGAL ENTITY THAT DERIVES MORE THAN TWENTY-FIVE PERCENT (25%) OF ITS NET REVENUES IN THE UNITED STATES FROM THE DEVELOPMENT, COMMERCIALIZATION, MANUFACTURE, SALE AND/OR MARKETINGS OF FINISHED DOSE PRODUCTS THAT ARE (1) PRODUCTS DESCRIBED IN ABBREVIATED NEW DRUG APPLICATIONS FILED WITH THE U.S. FOOD & DRUG ADMINISTRATION; (2) PRODUCTS SOLD AS AUTHORIZED GENERIC DRUGS IN THE U.S., (3) BIOSIMILAR PRODUCTS, AS DESCRIBED IN SECTION 351(K) OF THE PUBLIC HEALTH SERVICE ACT, AS AMENDED; AND/OR (4) DRUG EFFICACY STUDY IMPLEMENTATION (DESI) PRODUCTS. REGULAR MEMBERS HAVE FULL VOTING RIGHTS ON A "ONE COMPANY, ONE VOTE" BASIS. EACH REGULAR MEMBER SHALL DESIGNATE IN WRITING ONE PERSON TO EXERCISE THE RIGHTS OF THE REGULAR MEMBER IN THIS ASSOCIATION. FORM 990, PART VI, SECTION A, LINE 7A AAM'S VOTING MEMBERS ELECT THE DIRECTORS OF AAM'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B PURSUANT TO AAM'S BYLAWS, AAM'S BOARD OF DIRECTORS HAVE THE AUTHORITY TO AMEND THE BYLAWS. FURTHER, PURSUANT TO THE D.C. NOT-FOR-PROFIT CORPORATION ACT, EXTRAORDINARY ACTIONS MUST BE APPROVED BY THE VOTING MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B AAM STAFF AND LEGAL COUNSEL PROVIDED INITIAL REVIEW OF THE FORM 990. THE FORM 990 WAS THEN REVIEWED BY THE AUDIT AND FINANCE COMMITTEE. FINALLY, IT WAS FORWARDED TO ALL THE DIRECTORS OF THE BOARD BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C AAM REGULARLY AND CONSISTENTLY MONITORS COMPLIANCE WITH ITS CONFLICT OF INTEREST POLICY BY REMINDING DIRECTORS AND OTHERS SUBJECT TO THE POLICY PERIODICALLY OF THE APPLICABILITY OF THE POLICY AND THE APPROPRIATE MANNER OF COMPLYING WITH THE POLICY. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF THE PRESIDENT IS DETERMINED BASED ON THE PERFORMANCE OF THE PRESIDENT AND COMPARABLE SALARIES OF EXECUTIVES OF SIMILARLY SITUATED AND COMPETING TRADE ASSOCIATIONS IN THE WASHINGTON, DC METROPOLITAN AREA. COMPENSATION OF OTHER OFFICERS AND KEY EMPLOYEES IS DETERMINED BY THE PRESIDENT BASED ON COMPENSATION DATA OF SIMILARLY SITUATED EMPLOYEES AT SIMILARLY SITUATED AND COMPETING TRADE ASSOCIATIONS IN THE WASHINGTON, DC METROPOLITAN AREA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTANTS 1,832,962. LITIGATION FEES 1,047,728. OTHER PROFESSIONAL FEES 14,048. FORM 990, PART XII, LINE 2C: THE FINANCE AND AUDIT COMMITTEE OF THE BOARD OVERSEES THE AUDIT. FORM 990, PART IV, LINE 34 THE RELATED ASSOCIATION FOR ACCESSIBLE MEDICINES EDUCATION FOUNDATION CEASED OPERATIONS DURING 2023 AND FILED A FINAL 990N RETURN IN 2023. ASSOCIATION FOR ACCESSIBLE MEDICINES EDUCATION FOUNDATION 601 NEW JERSEY AVE NW STE 850 WASHINGTON DC 20001 453526383 EDUCATIONAL FOUNDATION DC 501(C)(3) LINE 7 ASSOCIATION FOR ACCESSIBLE MEDICINES 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 SCH R, PART II THE RELATED ASSOCIATION FOR ACCESSIBLE MEDICINES EDUCATION FOUNDATION CEASED OPERATIONS DURING 2023 AND FILED A FINAL 990N RETURN IN 2023.